ArticleNeurology. Clinical practice2025
Persistent MRI Abnormalities After Successful Treatment of Subarachnoid and Intraventricular Neurocysticercosis: A Case Series.
Article in Neurology. Clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA.EClinicalMedicine · 2026Article
- Neurocysticercosis in transition: expanding clinical spectrum, evolving diagnostics, and emerging therapies.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To describe the neuroimaging findings of patients after successful antiparasitic treatment for subarachnoid and intraventricular neurocysticercosis (NCC). Methods: In this retrospective case series, we reviewed brain MRIs for 6 patients cared for between 2015 and 2021 with confirmed subarachnoid or intraventricular NCC who were successfully treated, defined as a negative Results: On post-treatment MRIs obtained between 0 months and over 4 years after completion of therapy, all patients had persistently abnormal neuroimaging findings, including residual enhancing cysts and leptomeningeal and vascular enhancement, despite continued clinical improvement. Discussion: Persistent post-treatment MRI abnormalities are common in patients with NCC and do not necessarily warrant additional antiparasitic therapy. Although MRI remains a valuable tool for assessing overall treatment response, complete normalization of neuroimaging findings is uncommon in subarachnoid and intraventricular NCC.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.